• BioNTech gets more than $444M in funding from German federal government for Covid-19 vaccine

    13 days ago - By MedCity News

    The company is developing vaccines under the BNT162 program under a partnership with Pfizer. However, Pfizer has declined to accept government funding, and BioNTech said the New York-based drugmaker will continue to cover its own expenses.
    Read more ...